RSS Feeds
Acute Renal Failure and Ketorolac
- Gregory K. Buller, MD; and
- Mark A. Perazella, MD
- Yale University School of Medicine; New Haven, CT 06520
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
For more than 15 years, nonsteroidal antiinflammatory drugs (NSAIDs) have been associated with acute renal failure as a potential side effect. However, this phenomenon occurs only when renal blood flow significantly depends on renal vasodilator …
This 100-word excerpt has been provided in the absence of an abstract.
